UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021903
Receipt number R000024761
Scientific Title Identifying of index cancer among multiple cancer foci by methylation analysis using the ex vivo prostate needle biopsy from prostatectomy specimen
Date of disclosure of the study information 2016/06/01
Last modified on 2019/10/18 17:33:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Identifying of index cancer among multiple cancer foci by methylation analysis using the ex vivo prostate needle biopsy from prostatectomy specimen

Acronym

Identifying of index cancer by the prostate needle biopsy

Scientific Title

Identifying of index cancer among multiple cancer foci by methylation analysis using the ex vivo prostate needle biopsy from prostatectomy specimen

Scientific Title:Acronym

Identifying of index cancer by the prostate needle biopsy

Region

Japan


Condition

Condition

prostate cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To identify the index cancer which determine the patient prognosis among the multiple prostate cancer foci with methylation analysis using an ex vivo needle biopsy specimens to compare between prostate normal tissue and prostate cancer tissue

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase



Assessment

Primary outcomes

To identify the index cancer which determine the patient prognosis among the multiple prostate cancer foci with methylation analysis using ex vivo needle biopsy specimens to compare between prostate normal tissue and prostate cancer tissue

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Gene

Interventions/Control_1

Methylation analysis of prostate normal tissue and cancer tissue from multiple cancer foci, which are taken from ex vivo prostatectomy specimens by needle biopsy technique

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male

Key inclusion criteria

Inclusion criteria:
1) The patients who had histologically-confirmed prostate adenocarcinoma, agreed to undergo radical prostatectomy.
2) The patients had MR-visible prostate cancer lesion, confirmed by MRUS fusion biopsy.
3) The patients signed by themselves the informed consent document after understanding this study.



















Key exclusion criteria

Exclusion criteria:.
1) Prior or concurrent chemotherapy or androgen deprivation therapy for the prostate cancer.
2) Prior radiotherapy to the prostate or lower pelvis
3) Concurrent systemic steroids therapy for different disease
4) Unsuitable for participant due to mental disorder
5) The attending physician has determined inappropriate

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Osamu Ukimura

Organization

Kyoto Prefectural University of Medicine

Division name

Urology

Zip code


Address

Kajiicho465 Kamigyoku Kyoto

TEL

075-251-5595

Email

uro@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masakatsu Oishi

Organization

Kyoto Prefectural University of Medicine

Division name

Urology

Zip code


Address

Kajiicho465 Kamigyoku Kyoto

TEL

075-251-5595

Homepage URL


Email

uro@koto.kpu-m.ac.jp


Sponsor or person

Institute

The department of Urology, Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

The department of Urology, Kyoto Prefectural University of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 04 Month 01 Day

Date of IRB

2016 Year 11 Month 29 Day

Anticipated trial start date

2016 Year 12 Month 13 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 04 Month 14 Day

Last modified on

2019 Year 10 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024761


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name